“Intracellular delivery of NF-κB small interfering RNA for modulating therapeutic activities of classical anti-cancer drugs in human cervical cancer cells”, Drugs Ther Studies, vol. 3, no. 1, p. e7, Dec. 2013, doi: 10.4081/dts.2013.e7.